Venus Remedies, 526953, VENUSREM Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

495.92
17.41
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

469.15
N/A
1.02

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

0.25
11.53
0.45

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-7.98
13.11
2.28

PAT CAGR (%)

10 Years
5 Years
3 Years

-8.46
-
-24.51

P:E (Median)

8 Years
5 Years
3 Years

10.34
8.40
12.63

P:BV (Average)

8 Years
5 Years
3 Years

0.52
0.69
0.89

EV:EBITDA (Average)

8 Years
5 Years
3 Years

6.74
6.87
5.97

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var%
Net Sales 175.16 148.53 17.93% 131.23 109.45 19.90% 170.19 124.75 36.42% 98.63 154.93 -36.34%
Expenses 153.88 127.50 20.69% 118.23 102.37 15.49% 157.06 109.58 43.33% 85.16 136.68 -37.69%
EBITDA 21.28 21.03 1.19% 13.00 7.08 83.62% 13.13 15.17 -13.45% 13.47 18.25 -26.19%
EBIDTM 12.15% 14.16% 9.91% 6.47% 7.71% 12.16% 13.66% 11.78%
Other Income 3.91 3.24 20.68% 2.42 3.75 -35.47% 2.93 1.77 65.54% 2.06 1.41 46.10%
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 5.72 8.06 -29.03% 6.30 6.97 -9.61% 6.21 8.77 -29.19% 7.32 7.57 -3.30%
PBT 19.47 16.21 20.11% 9.12 3.86 136.27% 9.85 8.17 20.56% 8.21 12.09 -32.09%
Tax 6.96 8.67 -19.72% 0.93 1.25 -25.60% 4.40 0.44 900.00% 3.87 1.00 287.00%
PAT 12.51 7.54 65.92% 8.19 2.61 213.79% 5.45 7.73 -29.50% 4.34 11.09 -60.87%
PATM 7.14% 5.08% 6.24% 2.38% 3.20% 6.20% 4.40% 7.16%
EPS 9.34 5.63 65.90% 6.11 1.95 213.33% 4.07 5.77 -29.46% 3.24 8.28 -60.87%

Description Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var%
Net Sales 195.16 155.64 25.39% 143.42 116.90 22.69% 167.72 139.89 19.89% 95.15 143.08 -33.50%
Expenses 175.68 131.03 34.08% 131.38 108.80 20.75% 149.93 126.92 18.13% 84.75 128.57 -34.08%
EBITDA 19.48 24.61 -20.85% 12.04 8.10 48.64% 17.79 12.97 37.16% 10.40 14.51 -28.33%
EBIDTM 9.98% 15.81% 8.39% 6.93% 10.61% 9.27% 10.93% 10.14%
Other Income 3.92 3.41 14.96% 2.35 3.81 -38.32% 3.05 1.79 70.39% 2.26 1.44 56.94%
Interest 0.02 0.00 0 0.07 0.15 -53.33% 0.06 0.00 0 0.06 0.26 -76.92%
Depreciation 5.91 8.29 -28.71% 6.54 7.22 -9.42% 6.44 8.99 -28.36% 7.55 7.80 -3.21%
PBT 17.47 19.73 -11.45% 7.78 4.54 71.37% 14.34 5.77 148.53% 5.05 7.89 -35.99%
Tax 6.96 8.67 -19.72% 0.93 1.25 -25.60% 4.40 0.44 900.00% 3.87 1.00 287.00%
PAT 10.51 11.06 -4.97% 6.85 3.29 108.21% 9.94 5.33 86.49% 1.18 6.89 -82.87%
PATM 5.39% 7.11% 4.78% 2.81% 5.93% 3.81% 1.24% 4.82%
EPS 7.86 8.27 -4.96% 5.12 2.46 108.13% 7.43 3.99 86.22% 0.88 5.15 -82.91%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 575.21 537.66 576.71 514.62 320.23 301.84 355.07 375.45 402.69 451.88 526.06 Net Sales Growth 6.98% -6.77% 12.07% 60.70% 6.09% -14.99% -5.43% -6.76% -10.89% -14.10% Cost Of Goods Sold 352.23 336.70 377.50 336.68 176.81 181.78 205.42 186.69 194.64 213.05 298.96 Gross Profit 222.98 200.96 199.22 177.94 143.42 120.06 149.65 188.76 208.05 238.82 227.10 GP Margin 38.76% 37.38% 34.54% 34.58% 44.79% 39.78% 42.15% 50.28% 51.67% 52.85% 43.17% Total Expenditure 514.33 476.14 507.89 467.76 277.16 267.55 311.51 328.16 323.14 364.94 392.83 Power & Fuel Cost - 4.17 3.78 3.39 3.41 3.50 3.02 3.08 2.90 3.28 3.11 % Of Sales - 0.78% 0.66% 0.66% 1.06% 1.16% 0.85% 0.82% 0.72% 0.73% 0.59% Employee Cost - 47.67 43.75 35.89 33.79 30.26 27.82 25.02 25.02 27.26 25.57 % Of Sales - 8.87% 7.59% 6.97% 10.55% 10.03% 7.84% 6.66% 6.21% 6.03% 4.86% Manufacturing Exp. - 25.46 25.48 20.63 18.35 18.98 34.28 75.01 58.94 73.60 20.75 % Of Sales - 4.74% 4.42% 4.01% 5.73% 6.29% 9.65% 19.98% 14.64% 16.29% 3.94% General & Admin Exp. - 18.63 15.01 13.76 15.22 9.79 11.86 12.20 10.85 14.36 13.81 % Of Sales - 3.47% 2.60% 2.67% 4.75% 3.24% 3.34% 3.25% 2.69% 3.18% 2.63% Selling & Distn. Exp. - 43.24 42.37 57.40 29.59 23.24 29.11 26.17 30.78 33.39 30.64 % Of Sales - 8.04% 7.35% 11.15% 9.24% 7.70% 8.20% 6.97% 7.64% 7.39% 5.82% Miscellaneous Exp. - 0.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 30.64 % Of Sales - 0.05% 0% 0% 0% 0% 0% 0% 0% 0% 0% EBITDA 60.88 61.52 68.82 46.86 43.07 34.29 43.56 47.29 79.55 86.94 133.23 EBITDA Margin 10.58% 11.44% 11.93% 9.11% 13.45% 11.36% 12.27% 12.60% 19.75% 19.24% 25.33% Other Income 11.32 10.17 8.43 17.76 3.58 4.51 1.19 3.10 0.67 0.55 0.41 Interest 0.00 0.00 0.00 12.73 13.05 25.15 35.44 35.87 36.74 40.70 29.29 Depreciation 25.55 31.37 32.58 34.28 31.05 32.95 32.73 39.32 40.47 44.74 38.61 PBT 46.65 40.33 44.67 17.62 2.55 -19.30 -23.42 -24.80 3.01 2.04 65.73 Tax 16.16 11.36 -4.32 -13.21 1.96 -1.15 3.16 -4.56 1.81 -2.51 4.78 Tax Rate 34.64% 28.17% -9.67% -32.17% -31.31% 4.07% -13.49% 18.39% 60.13% -123.04% 7.27% PAT 30.49 28.96 48.99 54.27 -8.23 -27.11 -26.58 -20.24 1.20 4.55 60.95 PAT before Minority Interest 30.49 28.96 48.99 54.27 -8.23 -27.11 -26.58 -20.24 1.20 4.55 60.95 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.30% 5.39% 8.49% 10.55% -2.57% -8.98% -7.49% -5.39% 0.30% 1.01% 11.59% PAT Growth 5.25% -40.89% -9.73% - - - - - -73.63% -92.53% EPS 22.75 21.61 36.56 40.50 -6.14 -20.23 -19.84 -15.10 0.90 3.40 45.49

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 601.45 555.51 600.18 548.12 339.33 321.89 372.41 400.04 418.27 463.99 541.56 Net Sales Growth 8.27% -7.44% 9.50% 61.53% 5.42% -13.57% -6.91% -4.36% -9.85% -14.32% Cost Of Goods Sold 354.69 330.99 386.98 340.79 174.31 181.95 205.08 227.07 238.51 268.94 300.00 Gross Profit 246.76 224.51 213.20 207.33 165.02 139.94 167.33 172.97 179.77 195.05 241.55 GP Margin 41.03% 40.42% 35.52% 37.83% 48.63% 43.47% 44.93% 43.24% 42.98% 42.04% 44.60% Total Expenditure 541.74 495.31 538.07 494.35 298.52 289.37 332.94 349.32 337.11 374.81 403.33 Power & Fuel Cost - 5.52 4.71 4.58 4.73 4.86 4.29 4.14 4.01 3.80 3.38 % Of Sales - 0.99% 0.78% 0.84% 1.39% 1.51% 1.15% 1.03% 0.96% 0.82% 0.62% Employee Cost - 57.05 52.33 46.02 46.02 42.10 39.31 34.27 32.44 32.36 30.45 % Of Sales - 10.27% 8.72% 8.40% 13.56% 13.08% 10.56% 8.57% 7.76% 6.97% 5.62% Manufacturing Exp. - 32.40 31.57 22.86 20.84 21.01 36.10 42.48 15.70 17.29 22.10 % Of Sales - 5.83% 5.26% 4.17% 6.14% 6.53% 9.69% 10.62% 3.75% 3.73% 4.08% General & Admin Exp. - 20.70 16.67 16.45 17.57 11.85 13.52 13.26 11.97 15.67 14.74 % Of Sales - 3.73% 2.78% 3.00% 5.18% 3.68% 3.63% 3.31% 2.86% 3.38% 2.72% Selling & Distn. Exp. - 48.40 45.80 63.64 35.05 27.60 34.65 28.10 34.48 36.75 32.65 % Of Sales - 8.71% 7.63% 11.61% 10.33% 8.57% 9.30% 7.02% 8.24% 7.92% 6.03% Miscellaneous Exp. - 0.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 32.65 % Of Sales - 0.05% 0% 0% 0% 0% 0% 0% 0% 0% 0% EBITDA 59.71 60.20 62.11 53.77 40.81 32.52 39.47 50.72 81.16 89.18 138.23 EBITDA Margin 9.93% 10.84% 10.35% 9.81% 12.03% 10.10% 10.60% 12.68% 19.40% 19.22% 25.52% Other Income 11.58 10.32 8.31 19.63 5.31 6.09 2.39 4.28 2.01 0.68 0.47 Interest 0.21 0.29 0.48 13.02 13.34 25.41 35.56 36.38 37.98 41.21 29.40 Depreciation 26.44 32.30 33.53 35.28 32.01 33.98 33.83 40.26 41.68 46.00 40.22 PBT 44.64 37.93 36.41 25.11 0.78 -20.77 -27.53 -21.64 3.51 2.65 69.08 Tax 16.16 11.36 -4.32 -13.21 1.96 -1.15 3.16 -4.56 1.81 -2.51 4.78 Tax Rate 36.20% 29.95% -11.86% -27.21% -24.41% 3.87% -11.48% 21.07% 51.57% -94.72% 6.92% PAT 28.48 26.57 40.72 61.77 -10.00 -28.57 -30.69 -17.08 1.70 5.16 64.30 PAT before Minority Interest 28.48 26.57 40.72 61.77 -10.00 -28.57 -30.69 -17.08 1.70 5.16 64.30 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.74% 4.78% 6.78% 11.27% -2.95% -8.88% -8.24% -4.27% 0.41% 1.11% 11.87% PAT Growth 7.19% -34.75% -34.08% - - - - - -67.05% -91.98% EPS 21.25 19.83 30.39 46.10 -7.46 -21.32 -22.90 -12.75 1.27 3.85 47.99

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 478.05 449.41 400.18 332.25 340.95 367.99 394.23 444.43 466.24 467.42 Share Capital 13.37 13.37 12.34 12.34 12.34 12.34 12.34 11.44 11.44 11.44 Total Reserves 464.68 436.05 374.09 319.91 328.61 355.65 381.89 432.99 454.79 455.97 Non-Current Liabilities 58.17 45.95 58.81 96.03 136.75 157.89 179.52 212.03 221.50 161.27 Secured Loans 0.00 0.00 0.00 23.92 60.88 86.02 112.69 134.55 150.91 114.28 Unsecured Loans 38.68 38.68 47.52 48.34 55.20 50.84 49.13 56.47 51.34 25.22 Long Term Provisions 8.85 7.95 7.38 6.63 5.32 4.50 4.29 3.79 3.78 3.31 Current Liabilities 72.67 82.61 87.82 215.98 254.46 222.61 193.71 177.59 157.06 207.33 Trade Payables 48.51 49.63 68.36 33.96 33.41 27.19 30.56 23.90 25.76 28.14 Other Current Liabilities 23.27 32.23 18.78 99.99 107.61 76.87 45.70 36.63 13.99 54.12 Short Term Borrowings 0.00 0.00 0.00 81.42 108.92 117.23 115.70 115.09 115.40 110.08 Short Term Provisions 0.89 0.75 0.68 0.61 4.52 1.32 1.76 1.97 1.91 14.99 Total Liabilities 608.89 577.97 546.81 644.26 732.16 748.49 767.46 834.05 844.80 836.02 Net Block 199.68 224.67 244.20 271.47 346.89 369.93 389.38 433.52 425.77 416.09 Gross Block 568.50 578.19 581.73 589.77 674.06 669.01 655.78 660.61 612.50 555.61 Accumulated Depreciation 368.82 353.52 337.53 318.30 327.17 299.08 266.40 227.09 186.73 139.52 Non Current Assets 290.57 313.57 333.08 360.33 478.57 499.96 517.54 575.53 618.72 567.61 Capital Work in Progress 26.10 25.23 25.11 24.63 64.76 64.76 66.25 80.37 78.30 67.80 Non Current Investment 0.14 0.14 0.14 0.14 0.14 0.14 28.74 28.74 28.74 28.74 Long Term Loans & Adv. 62.55 61.96 62.34 64.08 66.78 65.13 33.17 32.90 85.91 54.98 Other Non Current Assets 2.11 1.57 1.29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 318.32 264.41 213.74 283.94 253.59 248.53 249.93 258.53 226.08 268.41 Current Investments 20.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 113.60 125.63 119.69 136.44 140.94 135.98 139.69 137.69 140.44 141.46 Sundry Debtors 84.92 30.41 16.44 29.78 31.39 44.15 41.91 53.88 59.37 62.80 Cash & Bank 52.57 49.97 30.24 1.44 1.28 3.64 3.15 3.04 3.52 4.38 Other Current Assets 47.09 5.25 5.70 55.72 79.98 64.77 65.18 63.91 22.76 59.77 Short Term Loans & Adv. 44.46 53.15 41.66 60.56 74.83 59.93 65.18 63.91 22.76 59.77 Net Current Assets 245.65 181.80 125.92 67.96 -0.87 25.93 56.22 80.94 69.02 61.08 Total Assets 608.89 577.98 546.82 644.27 732.16 748.49 767.47 834.06 844.80 836.02

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 460.34 440.45 400.28 323.37 332.52 361.91 388.67 437.62 456.68 461.61 Share Capital 13.37 13.37 12.34 12.34 12.34 12.34 12.34 11.44 11.44 11.44 Total Reserves 446.97 427.08 374.19 311.03 320.18 349.57 376.33 426.18 445.24 450.17 Non-Current Liabilities 58.17 45.95 58.12 95.82 136.68 158.47 179.52 212.05 221.55 161.75 Secured Loans 0.00 0.00 0.09 24.19 61.29 86.60 112.69 134.57 150.95 114.76 Unsecured Loans 38.68 38.68 46.74 47.87 54.73 50.84 49.13 56.47 51.34 25.22 Long Term Provisions 8.85 7.95 7.38 6.63 5.32 4.50 4.29 3.79 3.78 3.31 Current Liabilities 82.57 92.74 97.45 224.58 263.62 230.38 196.81 193.14 162.83 210.99 Trade Payables 50.84 50.17 71.36 36.70 36.00 29.33 29.73 25.14 29.56 31.22 Other Current Liabilities 27.23 37.76 21.10 101.70 110.30 78.47 46.16 42.71 15.96 54.70 Short Term Borrowings 3.61 4.06 4.30 85.58 112.80 121.26 119.16 123.32 115.40 110.08 Short Term Provisions 0.89 0.75 0.68 0.61 4.52 1.32 1.76 1.97 1.91 14.99 Total Liabilities 601.08 579.14 555.85 643.77 732.82 750.76 765.00 842.81 841.06 834.35 Net Block 215.96 240.94 261.68 289.37 364.45 389.20 406.18 452.48 443.65 439.46 Gross Block 603.75 612.50 616.32 623.96 707.02 702.77 686.50 679.57 641.12 587.38 Accumulated Depreciation 387.78 371.57 354.63 334.59 342.57 313.57 280.32 227.09 197.47 147.93 Non Current Assets 278.12 301.10 321.82 349.77 467.39 490.50 505.60 565.75 607.85 562.24 Capital Work in Progress 26.10 25.23 25.11 24.63 64.76 64.76 66.25 80.37 78.30 67.80 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 33.95 33.36 35.03 35.77 38.18 36.53 33.17 32.90 85.91 54.98 Other Non Current Assets 2.11 1.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 322.96 278.04 234.03 294.00 265.43 260.27 259.41 277.07 233.21 272.11 Current Investments 20.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 119.94 125.64 119.99 141.12 142.73 138.17 140.60 143.29 142.87 142.26 Sundry Debtors 76.66 38.60 32.04 30.69 38.04 47.27 47.29 61.59 63.22 64.99 Cash & Bank 53.72 50.40 31.42 2.13 2.81 3.98 3.56 7.07 3.62 4.41 Other Current Assets 52.51 5.01 5.70 55.72 81.85 70.84 67.96 65.12 23.51 60.47 Short Term Loans & Adv. 50.73 58.39 44.88 64.34 76.70 66.00 67.96 65.12 23.51 60.47 Net Current Assets 240.39 185.30 136.59 69.43 1.81 29.88 62.59 83.93 70.38 61.12 Total Assets 601.08 579.14 555.85 643.77 732.82 750.77 765.01 842.82 841.06 834.35

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 28.05 41.00 132.34 77.75 43.65 51.58 61.77 41.91 66.76 52.56 PBT 40.33 44.67 17.62 2.55 -19.30 -23.42 -24.80 3.01 2.04 65.73 Adjustment 22.25 24.83 21.59 40.39 59.20 64.73 69.30 53.72 81.90 35.95 Changes in Working Capital -34.53 -28.50 69.69 20.37 3.75 10.27 17.27 -14.82 -17.18 -49.12 Cash after chg. in Working capital 28.05 41.00 108.89 63.31 43.65 51.58 61.77 41.91 66.76 52.56 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 23.44 14.44 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -50.81 -16.75 55.98 -4.64 -11.27 -11.48 -18.06 3.20 -67.15 -93.75 Net Fixed Assets 8.82 3.42 7.56 124.42 -5.05 -11.74 18.95 -50.18 -67.39 -93.77 Net Investments -20.13 0.00 0.00 0.00 0.00 28.60 0.00 0.00 0.00 0.00 Others -39.50 -20.17 48.42 -129.06 -6.22 -28.34 -37.01 53.38 0.24 0.02 Cash from Financing Activity 0.00 -9.13 -161.88 -72.35 -34.74 -39.61 -43.60 -45.59 -0.47 39.31 Net Cash Inflow / Outflow -22.76 15.12 26.45 0.76 -2.36 0.49 0.11 -0.48 -0.86 -1.88 Opening Cash & Equivalents 42.83 27.70 0.00 0.50 3.64 3.15 3.04 3.52 4.38 6.26 Closing Cash & Equivalent 20.07 42.83 26.45 1.26 1.28 3.64 3.15 3.04 3.52 4.38

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 36.63 41.10 131.84 77.60 45.33 31.19 58.93 46.88 67.80 52.65 PBT 37.93 36.41 25.11 0.78 -20.77 -27.53 -21.64 3.51 2.65 69.08 Adjustment 23.33 26.33 21.89 41.56 60.72 66.24 70.61 56.41 83.56 37.21 Changes in Working Capital -24.63 -21.64 61.39 20.82 5.37 -7.52 9.96 -13.04 -18.40 -53.65 Cash after chg. in Working capital 36.63 41.10 108.39 63.16 45.33 31.19 58.93 46.88 67.80 52.65 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 23.44 14.44 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -50.83 -16.73 56.49 -4.75 -11.33 -11.48 -18.32 2.92 -67.18 -94.66 Net Fixed Assets 8.82 3.42 7.56 124.42 -5.05 -11.74 18.95 -50.18 -67.39 -93.77 Net Investments -20.13 0.00 0.00 0.00 0.00 28.60 0.00 0.00 0.00 0.00 Others -39.52 -20.15 48.93 -129.17 -6.28 -28.34 -37.27 53.10 0.21 -0.89 Cash from Financing Activity -0.57 -9.48 -162.24 -73.00 -35.17 -39.23 -44.13 -46.35 -1.42 40.06 Net Cash Inflow / Outflow -14.77 14.90 26.09 -0.15 -1.17 -19.52 -3.51 3.46 -0.79 -1.95 Opening Cash & Equivalents 43.26 28.88 1.94 2.03 3.98 0.00 7.07 3.62 4.41 6.36 Closing Cash & Equivalent 21.21 43.26 28.88 1.94 2.81 -19.52 3.56 7.07 3.62 4.41

Financial Ratios

Consolidated /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 357.63 336.21 313.10 269.21 276.25 298.16 319.42 388.42 407.48 408.51 ROA 4.88% 8.71% 9.11% -1.20% -3.66% -3.51% -2.53% 0.14% 0.54% 7.79% ROE 6.25% 11.72% 15.10% -2.44% -7.65% -6.98% -4.83% 0.26% 0.97% 14.26% ROCE 8.03% 9.55% 10.80% 1.15% -0.48% 1.75% 1.50% 5.11% 5.55% 13.40% Fixed Asset Turnover 0.94 0.99 0.88 0.51 0.45 0.54 0.57 0.63 0.77 1.02 Receivable days 39.15 14.83 16.39 34.86 45.68 44.23 46.56 51.33 49.34 40.15 Inventory Days 81.20 77.63 90.83 158.08 167.43 141.69 134.83 126.05 113.85 92.77 Payable days 53.20 57.04 55.46 42.49 37.63 31.43 27.90 25.33 24.89 20.07 Cash Conversion Cycle 67.15 35.41 51.76 150.45 175.48 154.49 153.50 152.04 138.30 112.85 Total Debt/Equity 0.08 0.09 0.12 0.65 0.86 0.82 0.78 0.74 0.68 0.62 Interest Cover 0.00 0.00 4.23 0.52 -0.12 0.34 0.31 1.08 1.05 3.24

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 344.38 329.50 313.18 262.01 269.42 293.23 314.92 382.47 399.13 403.43 ROA 4.50% 7.18% 10.30% -1.45% -3.85% -4.05% -2.12% 0.20% 0.62% 8.29% ROE 5.90% 9.85% 17.40% -3.05% -8.23% -8.18% -4.13% 0.38% 1.12% 15.38% ROCE 7.75% 7.89% 12.37% 0.90% -0.67% 1.17% 2.00% 5.35% 5.74% 14.06% Fixed Asset Turnover 0.91 0.98 0.88 0.51 0.46 0.54 0.59 0.63 0.76 0.99 Receivable days 37.87 21.48 20.89 36.97 48.37 46.34 49.67 54.45 50.42 37.72 Inventory Days 80.68 74.69 86.94 152.66 159.26 136.61 129.51 124.86 112.15 90.94 Payable days 55.69 57.31 57.86 42.82 37.91 30.30 26.74 26.74 27.25 21.28 Cash Conversion Cycle 62.86 38.86 49.96 146.80 169.72 152.65 152.44 152.57 135.32 107.37 Total Debt/Equity 0.09 0.10 0.13 0.68 0.90 0.85 0.80 0.77 0.70 0.63 Interest Cover 129.84 76.69 4.73 0.40 -0.17 0.23 0.41 1.09 1.06 3.35

Top Investors:

k.b.shekar

mc jain infoservices private limited

pradeep kumar jain

acadian emerging markets micro-cap equity master fund

investor education and protection fund (iepf)

llp

Annual Reports:

News Update:

Venus Remedies gets oncology tender from PAHO
19th Jun 2024, 10:50 AM

This prestigious tender award highlights Venus Remedies' commitment to advancing healthcare and its crucial role in the global battle against cancer
Read More
Venus Remedies secures award for antibiotic product Ceftriaxone 1gm from UNICEF
13th Jun 2024, 09:50 AM

UNICEF's decision to award the tender to Venus Remedies is a testament to its relentless pursuit of excellence in healthcare
Read More
Venus Remedies - Quarterly Results
30th May 2024, 20:54 PM

Read More

Venus Remedies Ltd.

Pharmaceuticals & Drugs

BSE: 526953 | NSE: VENUSREM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Venus Remedies Ltd.

Pharmaceuticals & Drugs

BSE: 526953 | NSE: VENUSREM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: